Heart Failure Nyha Class Ii clinical trials

Explore recruiting heart failure nyha class ii clinical trials.

Recruiting heart failure nyha class ii studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Heart Failure Nyha Class Ii trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Beneficial effects of vitamin D combined with oral iron supplementation in patients with chronic heart failure and iron deficiency (VICTORID-HF TRIAL)

Italy

Therapeutic use (Phase IV) EU CTIS Study details

Phase 2, Multicenter, Randomized, Parallel, 3-arm, Placebo-controlled Study to Assess Efficacy and Safety of CDR132L in Patients with Reduced Left Ventricular Ejection Fraction (≤ 45%) After Myocardial Infarction (HF-REVERT)

Poland, Spain, Czechia, Greece, Netherlands, Germany +1 more

Therapeutic exploratory (Phase II) EU CTIS Study details

A randomized, open-label, single dose, 2-way crossover bioequivalence study comparing apixaban 5 mg hard capsules (PG412 [Celon Pharma]) vs apixaban 5 mg film-coated tablets (Eliquis [Bristol-Myers Squibb]) under fasting conditions in healthy volunteers

Poland

Human Pharmacology (Phase I)- Bioequivalence Study EU CTIS Study details

A study comparing the new drug PG413 produced by Celon Pharma SA with the drug Eliquis available on the market in healthy volunteers.

Poland

Human Pharmacology (Phase I)- Bioequivalence Study EU CTIS Study details

Heart Failure Nyha Class Ii trials by city

Heart Failure Nyha Class Ii in Toronto Heart Failure Nyha Class Ii in Vancouver Heart Failure Nyha Class Ii in Montreal Heart Failure Nyha Class Ii in Calgary Heart Failure Nyha Class Ii in Edmonton Heart Failure Nyha Class Ii in Ottawa Heart Failure Nyha Class Ii in Winnipeg Heart Failure Nyha Class Ii in Quebec City Heart Failure Nyha Class Ii in Hamilton Heart Failure Nyha Class Ii in Kitchener Heart Failure Nyha Class Ii in London Heart Failure Nyha Class Ii in Halifax Heart Failure Nyha Class Ii in New York Heart Failure Nyha Class Ii in Los Angeles Heart Failure Nyha Class Ii in Chicago Heart Failure Nyha Class Ii in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease